Infection Control for Healthcare Level 2 (VTQ)

55 videos, 2 hours and 36 minutes

Course Content

Hepatitis D Virus

Video 13 of 55
1 min 45 sec
Want to watch this video? Sign up for the course or enter your email below to watch one free video.

Unlock This Video Now for FREE

This video is normally available to paying customers.
You may unlock this video for FREE. Enter your email address for instant access AND to receive ongoing updates and special discounts related to this topic.

Hepatitis D only affects people who are already infected with hepatitis B, because the hepatitis D virus needs the Hepatitis B virus to survive in the body.

Up to 10% of Hepatitis B virus carriers have anti-hepatitis D virus antibodies.

Hepatitis D virus is uncommon in the UK and is more widespread in certain parts of Europe, the Middle East, Africa and South America.

If someone has a long-term infection with hepatitis D and hepatitis B it can increase their risk of developing serious medical problems such as cirrhosis or liver cancer.

Co-infection with hepatitis D and B viruses rarely lead to chronic disease, but fulminant hepatitis is more likely than with hepatitis B virus alone.

Fulminant hepatitis is a rare syndrome of massive necrosis of the liver and a decrease in the size of the liver that usually occurs after infection with certain hepatitis viruses.

If someone has both hepatitis B and D viruses, this worsens the patient prognosis. It will make the condition worse in an otherwise healthy carrier and even mild hepatitis can become full-blown.  There is also an increased risk of chronic progressive disease, often terminating in cirrhosis.

There is no vaccine specifically for hepatitis D, but the hepatitis B vaccine can help protect against, so this is the form that prevention takes.